Haleon PLC Sponsored ADR

HLN Healthcare Drug Manufacturers Specialty & Generic

Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.

9.13 0.10 −1.08%
Market cap
$40.2B
P/E
20.5×
Fwd P/E
16.5×
Dividend yield
2.16%
F-score
8/9
Altman Z
3.04
Beneish M
−2.60
Dividend safety
63/100

Haleon PLC Sponsored ADR (HLN) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Haleon PLC Sponsored ADR (HLN) trades at a EV/FCF of 11.4×. Over the past ten years it has ranged from 0.0× (June 2024) to 13.5× (June 2025); the current reading is higher than 71% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 11.0× (5.21%)
FY2024 11.6× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/FCF Change
Sep 2024 12.7× —
Mar 2024 0.0× —
Sep 2023 0.0× —
Jun 2023 0.0× —
1 more quarters

Against its own ten years

Low 0.0× High 13.5×
Ten-year median 10.2×
Current reading's percentile 71

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on HLN